Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) EPS (Weighted Average and Diluted) (2022 - 2025)

GE HealthCare Technologies' EPS (Weighted Average and Diluted) history spans 4 years, with the latest figure at $1.29 for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) fell 17.83% year-over-year to $1.29, compared with a TTM value of $4.56 through Dec 2025, up 5.31%, and an annual FY2025 reading of $4.55, up 4.84% over the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $1.29 at GE HealthCare Technologies, up from $0.98 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $1.57 in Q4 2024, with the low at $0.41 in Q1 2023.
  • Average EPS (Weighted Average and Diluted) over 4 years is $1.01, with a median of $1.0 recorded in 2024.
  • Year-over-year, EPS (Weighted Average and Diluted) crashed 52.33% in 2023 and then skyrocketed 97.56% in 2024.
  • Tracing GEHC's EPS (Weighted Average and Diluted) over 4 years: stood at $1.21 in 2022, then decreased by 26.45% to $0.89 in 2023, then skyrocketed by 76.4% to $1.57 in 2024, then decreased by 17.83% to $1.29 in 2025.
  • Per Business Quant, the three most recent readings for GEHC's EPS (Weighted Average and Diluted) are $1.29 (Q4 2025), $0.98 (Q3 2025), and $1.06 (Q2 2025).